The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas
Open accessAbstract
SUMMARY Malignant melanoma is characterized by frequent metastasis, however specific changes that regulate this process have not been clearly delineated. Although it is well known that Wnt signaling is frequently dysregulated in melanoma, the functional implications of this observation are unclear. By modulating β-catenin levels in a mouse model of melanoma that is based on melanocyte-specific Pten loss and BrafV600E mutation, we demonstrate that β-catenin is a central mediator of melanoma metastasis to lymph node and lung. In addition to altering metastasis, β-catenin levels control tumor differentiation and regulate both MAPK/Erk and PI3K/Akt signaling. Highly metastatic tumors with β-catenin stabilization are very similar to a subset of human melanomas. Together these findings establish Wnt signaling as a metastasis regulator in melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Distinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
Self-citationStabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Intestinal polyposis in mice with a dominant stable mutation of the beta -catenin gene
Harada, N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.5931 · Cited by 1,212
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Self-citationBrault, V., Moore, R., Kutsch, S., Ishibashi, M., Rowitch, D. H., McMahon, A. P., Sommer, L., Boussadia, O., & Kemler, R. (2001) · Development · doi:10.1242/dev.128.8.1253 · Cited by 1,088
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
Forbes, S. A., Tang, G., Bindal, N., Bamford, S., Dawson, E., Cole, C., Kok, C. Y., Jia, M., Ewing, R., Menzies, A., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp995 · Cited by 573
Genetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in Melanoma
Tsao, H., Yang, G., Goel, V., Wu, H., & Haluska, F. G. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22243.x · Cited by 467
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation
Gupta, P. B., Kuperwasser, C., Brunet, J.-P., Ramaswamy, S., Kuo, W.-L., Gray, J. W., Naber, S. P., & Weinberg, R. A. (2005) · Nature Genetics · doi:10.1038/ng1634 · Cited by 439
Cheli, Y., Ohanna, M., Ballotti, R., & Bertolotto, C. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00653.x · Cited by 363
Oh, W. J., Wu, C. ‐., Kim, S. J., Facchinetti, V., Julien, L. ‐., Finlan, M., Roux, P. P., Su, B., & Jacinto, E. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.271 · Cited by 333
Chien, A. J., Moore, E. C., Lonsdorf, A. S., Kulikauskas, R. M., Rothberg, B. G., Berger, A. J., Major, M. B., Hwang, S. T., Rimm, D. L., & Moon, R. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811902106 · Cited by 332
Self-citationLineage-specific requirements of β-catenin in neural crest development
Hari, L., Brault, V., Kléber, M., Lee, H.-Y., Ille, F., Leimeroth, R., Paratore, C., Suter, U., Kemler, R., & Sommer, L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200209039 · Cited by 320
Delmas, V., Beermann, F., Martinozzi, S., Carreira, S., Ackermann, J., Kumasaka, M., Denat, L., Goodall, J., Luciani, F., Viros, A., et al. (2007) · Genes & Development · doi:10.1101/gad.450107 · Cited by 311
Widlund, H. R., Horstmann, M. A., Price, E. R., Cui, J., Lessnick, S. L., Wu, M., He, X., & Fisher, D. E. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202049 · Cited by 291
A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
Girardini, J. E., Napoli, M., Piazza, S., Rustighi, A., Marotta, C., Radaelli, E., Capaci, V., Jordan, L., Quinlan, P., Thompson, A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.004 · Cited by 286
Rimm, D. L., Caca, K., Hu, G., Harrison, F. B., & Fearon, E. R. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65278-9 · Cited by 283
Self-citationWang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., & Bishop, J. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1023 · Cited by 281
Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF
Wellbrock, C., Rana, S., Paterson, H., Pickersgill, H., Brummelkamp, T., & Marais, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002734 · Cited by 278
Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Dry, J. R., Pavey, S., Pratilas, C. A., Harbron, C., Runswick, S., Hodgson, D., Chresta, C., McCormack, R., Byrne, N., Cockerill, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1577 · Cited by 262
Recent Trends in Incidence of Cutaneous Melanoma among US Caucasian Young Adults
Purdue, M. P., Beane Freeman, L. E., Anderson, W. F., & Tucker, M. A. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.159 · Cited by 254
The WNT/Beta-catenin pathway in melanoma
Larue, L. (2006) · Frontiers in Bioscience · doi:10.2741/1831 · Cited by 250
E-cadherin is a survival factor for the lactating mouse mammary gland
Boussadia, O., Kutsch, S., Hierholzer, A., Delmas, V., & Kemler, R. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00090-4 · Cited by 248
Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development
Cheung, M., Sharma, A., Madhunapantula, S. V., & Robertson, G. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5867 · Cited by 196
Bedrosian, I., Faries, M. B., Guerry IV, D., Elenitsas, R., Schuchter, L., Mick, R., Spitz, F. R., Bucky, L. P., Alavi, A., Elder, D. E., et al. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0262-z · Cited by 164
Loss of beta-catenin expression associated with disease progression in malignant melanoma
Kageshita, T., Hamby, C. V., Ishihara, T., Matsumoto, K., Saida, T., & Ono, T. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04336.x · Cited by 138
Sanders, D., Blessing, K., Hassan, G. A., Bruton, R., Marsden, J., & Jankowski, J. A. (1999) · Molecular Pathology · doi:10.1136/mp.52.3.151 · Cited by 138
Tucci, M. G., Lucarini, G., Brancorsini, D., Zizzi, A., Pugnaloni, A., Giacchetti, A., Ricotti, G., & Biagini, G. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08246.x · Cited by 131
E-cadherin/catenin complex in benign and malignant melanocytic lesions
Silye, R., Karayiannakis, A. J., Syrigos, K. N., Poole, S., Noorden, S. V., Batchelor, W., Regele, H. M., Sega, W., Boesmueller, H., Krausz, T. N., et al. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199812)186:4<350::aid-path181>3.0.co;2-k · Cited by 120
REIFENBERGER, J., Knobbe-Thomsen, C. B., Wolter, M., Blaschke, B., Schulte, K. W., Pietsch, T., Ruzicka, T., & Reifenberger, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10512 · Cited by 115
Omholt, K., Platz, A., Ringborg, U. K., & Hansson, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1270 · Cited by 100
Liao, Y., Wei, Y., Zhou, X., Yang, J. Y., Dai, C., Chen, Y. J., Agarwal, N., Sarbassov, D. D., Shi, D., Yu, D., et al. (2009) · Oncogene · doi:10.1038/onc.2009.98 · Cited by 94
Control of melanocyte differentiation by a MITF–PDE4D3 homeostatic circuitPreprint
Khaled, M., Levy, C., & Fisher, D. E. (2010) · Genes & Development · doi:10.1101/gad.1937710 · Cited by 92
Demunter, A., Libbrecht, L. J., Degreef, H. J., Wolf‐Peeters, C. D., & van den Oord, J. J. (2002) · Modern Pathology · doi:10.1038/modpathol.3880546 · Cited by 84
Ugurel, S., Houben, R., Schrama, D., Voigt, H., Zapatka, M., Schadendorf, D., Bröcker, E., & Becker, J. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2682 · Cited by 83
Kielhorn, E., Provost, E., Olsen, D. A., D'Aquila, T. G., Smith, B. L., Camp, R. L., & Rimm, D. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10893 · Cited by 79
Self-citationNakatsu, Y., Sakoda, H., Kushiyama, A., Zhang, J., Ono, H., Fujishiro, M., Kikuchi, T., Fukushima, T., Yoneda, M., Ohno, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.206904 · Cited by 69
Prognostic Significance of Cadherin-Based Adhesion Molecules in Cutaneous Malignant Melanoma
Kreizenbeck, G. M., Berger, A. J., Subtil, A., Rimm, D. L., & Rothberg, B. E. G. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2729 · Cited by 68
Self-citationMelanoma biomarker expression in melanocytic tumor progression: a tissue microarray study
Nazarian, R. M., Prieto, V. G., Elder, D. E., & Duncan, L. M. (2010) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2010.01505.x · Cited by 65
Identification of direct transcriptional targets of V600EBRAF/MEK signalling in melanoma
Packer, L., East, P., Reis-Filho, J. S., & Marais, R. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00618.x · Cited by 62
Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression
Li, H., Wang, S., Zhu, T., Zhou, J., Xu, Q., Lu, Y., & Ma, D. (2006) · Oncology Reports · doi:10.3892/or.16.3.491 · Cited by 33
Role of Pin1 in UVA-induced cell proliferation and malignant transformation in epidermal cells
Han, C. Y., Hiền, T. T., Lim, S., & Kang, K. W. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.106 · Cited by 17
Zhang, D., O’Neil, M. F., Cunningham, M. T., Fan, F., Olyaee, M. S., & Li, L. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428191003695645 · Cited by 14
Cited by
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Salmon, H., Idoyaga, J., Rahman, A., Leboeuf, M., Remark, R., Jordan, S., Casanova-Acebes, M., Khudoynazarova, M., Agudo, J., Tung, N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.012 · Cited by 1,201
Self-citationProspects for combining targeted and conventional cancer therapy with immunotherapy
Gotwals, P., Cameron, S., Cipolletta, D., Cremasco, V., Crystal, A., Hewes, B., Mueller, B., Quaratino, S., Sabatos-Peyton, C., Petruzzelli, L., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.17 · Cited by 953
Metadata
- Authors
- Damsky, W. E., Curley, D. P., Santhanakrishnan, M., Rosenbaum, L. E., Platt, J. T., Gould Rothberg, B. E., Taketo, M. M., Dankort, D., Rimm, D. L., McMahon, M., & Bosenberg, M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 20
- Issue
- 6
- Pages
- 741-754
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2157873170
- Cited by
- 351
- References
- 50
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.